The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Is BPC 157 Legal? Understanding Its Status and Implications What Science ACTUALLY Says About BPC 157 Benefits Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law FDA moves toward easing restrictions on certain peptides BioPharma Dive